Phase III Failure Sinks Drug for Rare Neurological Disorder
The Italian biotech Newron is halting the development of the experimental drug sarizotan after it…
08/05/2020 - 4 minutes
Newron
British Researchers Find Thought Police to Treat Neurological Disorders
Cambridge University scientists have identified a chemical in the brain that blocks unwanted thoughts, offering a…
07/11/2017 - 3 minutes
Buongiorno Biotech! Top 4 Companies Making Milan Europe’s Next Biotech Hub
Italy may not be the first country that comes to mind when you think of…
10/10/2017 - 7 minutes
UPDATE: Italian Pharma receives €11M for Parkinson’s Drug Approval
UPDATE (12/05/2017): Newron has received €11.3M as a milestone payment for the approval from its…
12/05/2017 - 2 minutes
Newron’s Journey to Launch the First Parkinson’s Drug in 11 Years
Philip talked to Stefan Weber, CEO of Newron Pharmaceuticals, in our first meetup in Munich…
20/04/2017 - 2 minutes
Infographic: The Biggest Biotech Company in Each European Country
We had a look into European biotech and created a map with the biggest biotech…
21/02/2017 - 2 minutes
World Mental Health Day: How is Biotech Helping the Cause?
Biotech is one of the main forces driving the development of effective therapies to treat neurological and…
11/10/2016 - 4 minutes
New Italian Drug is FDA approved for trials in Rare Neurological Disease
Newron sees its Investigational New Drug application approved by the FDA. It can now begin…
17/05/2016 - 2 minutes
Swissmedic Approves Zambon and Newron Therapy against Parkinson’s
Italian Pharma Newron and its partner Zambon (from Milan) have been granted a license by Swissmedic…
16/11/2015 - 2 minutes
Newron’s ressurection story continues with a FDA Orphan Drug designation
New success for Newron Pharmaceuticals. The FDA approved Orphan Drug designation to its new chemical…
14/07/2015 - 2 minutes
Newron raised new funds to continue the development of Neurological therapies
Newron Pharmaceuticals, a public company focused on novel Central Nervous System (CNS) and pain therapies, announces…
02/05/2015 - 2 minutes
